Healthlead PCL (BKK:HL)

Market Cap	2.08B
Revenue (ttm)	2.19B
Net Income (ttm)	85.23M
Shares Out	266.48M
EPS (ttm)	0.31
PE Ratio	24.86
Forward PE	n/a
Dividend	0.17 (2.19%)
Ex-Dividend Date	Mar 14, 2025

Volume	24,200
Average Volume	126,920
Open	7.85
Previous Close	7.75
Day's Range	7.70 - 7.85
52-Week Range	5.65 - 11.30
Beta	0.25
RSI	77.00
Earnings Date	Nov 13, 2025

About Healthlead PCL

Healthlead Public Company Limited, together with its subsidiaries, engages in developing, importing, and distributing drugs, pharmaceuticals, cosmetic products, dietary supplements, medical devices, other healthcare products. It offers medicines, medical supplies, and medical devices, as well as disinfectant and deodorizing products comprising mask products under the iCare, Pharmax, vitaminclub, and Super Drug brands; and dietary supplements under the PRIME and Besuto brand names. Healthlead Public Company Limited was incorporated in 2018 and i...

• Industry: Medical Distribution
• Sector: Healthcare
• Founded: 2018
• Country: Thailand
• Stock Exchange: Stock Exchange of Thailand
• Ticker Symbol: HL

Financial Performance

In 2024, Healthlead PCL's revenue was 2.01 billion, an increase of 21.22% compared to the previous year's 1.66 billion. Earnings were 78.26 million, an increase of 4.80%.